# Skywest Inc: financial statements, quarterly

SKYW · Nasdaq · CIK 793733 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/skyw.md) · [Financials](/companies/skyw/financials.md) · [Filings](/companies/skyw/filings.md) · [Insiders](/companies/skyw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/skyw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [766](/filings/0001558370-24-014135.md) | [752 d](/filings/0001104659-26-016358.md) | [804](/filings/0001558370-25-005551.md) | [867](/filings/0001558370-25-009609.md) | [913](/filings/0001104659-25-104919.md) | [944 d](/filings/0001104659-26-016358.md) | [948](/filings/0001104659-26-048542.md) | [1,035](/filings/0001104659-26-086641.md) | [1,050](/filings/0001104659-25-104919.md) | [1,024 d](/filings/0001104659-26-016358.md) | [1,013](/filings/0001104659-26-048542.md) | [1,103](/filings/0001104659-26-086641.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [49.3](/filings/0001558370-24-014135.md) | [27.6 d](/filings/0001104659-26-016358.md) | [99.5](/filings/0001558370-25-005551.md) | [120](/filings/0001558370-25-009609.md) | [131](/filings/0001104659-25-104919.md) | [144 d](/filings/0001104659-26-016358.md) | [139](/filings/0001104659-26-048542.md) | [170](/filings/0001104659-26-086641.md) | [174](/filings/0001104659-25-104919.md) | [134 d](/filings/0001104659-26-016358.md) | [124](/filings/0001104659-26-048542.md) | [156](/filings/0001104659-26-086641.md) |
| Interest expense | $m | [32.5](/filings/0001558370-23-016945.md) | [31.0 d](/filings/0001558370-24-001237.md) | [29.8](/filings/0001558370-24-005892.md) | [29.0](/filings/0001558370-25-009609.md) | [27.8](/filings/0001104659-25-104919.md) | [27.7 d](/filings/0001104659-26-016358.md) | [27.1](/filings/0001104659-26-048542.md) | [26.6](/filings/0001104659-26-086641.md) | [25.6](/filings/0001104659-25-104919.md) | [25.2 d](/filings/0001104659-26-016358.md) | [24.5](/filings/0001104659-26-048542.md) | [24.9](/filings/0001104659-26-086641.md) |
| Income tax | $m | [0.9](/filings/0001558370-24-014135.md) | [6.9 d](/filings/0001104659-26-016358.md) | [19.9](/filings/0001558370-25-005551.md) | [26.6](/filings/0001558370-25-009609.md) | [26.5](/filings/0001104659-25-104919.md) | [36.2 d](/filings/0001104659-26-016358.md) | [20.2](/filings/0001104659-26-048542.md) | [42.8](/filings/0001104659-26-086641.md) | [40.8](/filings/0001104659-25-104919.md) | [33.4 d](/filings/0001104659-26-016358.md) | [6.1](/filings/0001104659-26-048542.md) | [38.2](/filings/0001104659-26-086641.md) |
| Net income | $m | [23.5](/filings/0001558370-24-014135.md) | [17.5 d](/filings/0001104659-26-016358.md) | [60.3](/filings/0001104659-25-104919.md) | [75.6](/filings/0001104659-25-104919.md) | [89.7](/filings/0001104659-25-104919.md) | [97.4 d](/filings/0001104659-26-016358.md) | [101](/filings/0001104659-26-086641.md) | [120](/filings/0001104659-26-086641.md) | [116](/filings/0001104659-25-104919.md) | [91.2 d](/filings/0001104659-26-016358.md) | [102](/filings/0001104659-26-086641.md) | [101](/filings/0001104659-26-086641.md) |
| Diluted EPS | $ per share | [0.55](/filings/0001558370-24-014135.md) | not reported | [1.45](/filings/0001558370-25-005551.md) | [1.82](/filings/0001558370-25-009609.md) | [2.16](/filings/0001104659-25-104919.md) | not reported | [2.42](/filings/0001104659-26-048542.md) | [2.91](/filings/0001104659-26-086641.md) | [2.81](/filings/0001104659-25-104919.md) | not reported | [2.50](/filings/0001104659-26-048542.md) | [2.54](/filings/0001104659-26-086641.md) |
| Basic EPS | $ per share | [0.56](/filings/0001558370-24-014135.md) | not reported | [1.50](/filings/0001558370-25-005551.md) | [1.88](/filings/0001558370-25-009609.md) | [2.23](/filings/0001104659-25-104919.md) | not reported | [2.48](/filings/0001104659-26-048542.md) | [2.98](/filings/0001104659-26-086641.md) | [2.89](/filings/0001104659-25-104919.md) | not reported | [2.54](/filings/0001104659-26-048542.md) | [2.55](/filings/0001104659-26-086641.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [125](/filings/0001558370-23-016945.md) | [148](/filings/0001558370-25-000943.md) | [180](/filings/0001558370-24-005892.md) | [142](/filings/0001558370-24-010241.md) | [178](/filings/0001558370-24-014135.md) | [227](/filings/0001104659-26-016358.md) | [179](/filings/0001558370-25-005551.md) | [48.3](/filings/0001558370-25-009609.md) | [44.5](/filings/0001104659-25-104919.md) | [123](/filings/0001104659-26-086641.md) | [65.8](/filings/0001104659-26-048542.md) | [81.4](/filings/0001104659-26-086641.md) |
| Current assets | $m | [1,162](/filings/0001558370-23-016945.md) | [1,132](/filings/0001558370-25-000943.md) | [1,069](/filings/0001558370-24-005892.md) | [1,115](/filings/0001558370-24-010241.md) | [1,134](/filings/0001558370-24-014135.md) | [1,117](/filings/0001104659-26-016358.md) | [1,071](/filings/0001558370-25-005551.md) | [1,062](/filings/0001558370-25-009609.md) | [1,100](/filings/0001104659-25-104919.md) | [1,091](/filings/0001104659-26-086641.md) | [1,013](/filings/0001104659-26-048542.md) | [1,024](/filings/0001104659-26-086641.md) |
| Total assets | $m | [7,059](/filings/0001558370-24-014135.md) | [7,026](/filings/0001104659-26-016358.md) | [6,983](/filings/0001558370-25-005551.md) | [6,962](/filings/0001558370-25-009609.md) | [6,957](/filings/0001104659-25-104919.md) | [7,140](/filings/0001104659-26-016358.md) | [7,114](/filings/0001104659-26-048542.md) | [7,174](/filings/0001104659-26-086641.md) | [7,214](/filings/0001104659-25-104919.md) | [7,386](/filings/0001104659-26-086641.md) | [7,346](/filings/0001104659-26-048542.md) | [7,412](/filings/0001104659-26-086641.md) |
| Current liabilities | $m | [1,206](/filings/0001558370-23-016945.md) | [1,254](/filings/0001558370-25-000943.md) | [1,312](/filings/0001558370-24-005892.md) | [1,324](/filings/0001558370-24-010241.md) | [1,314](/filings/0001558370-24-014135.md) | [1,430](/filings/0001104659-26-016358.md) | [1,417](/filings/0001558370-25-005551.md) | [1,458](/filings/0001558370-25-009609.md) | [1,553](/filings/0001104659-25-104919.md) | [1,668](/filings/0001104659-26-086641.md) | [1,634](/filings/0001104659-26-048542.md) | [1,800](/filings/0001104659-26-086641.md) |
| Long-term debt | $m | [2,634](/filings/0001558370-23-016945.md) | [2,562](/filings/0001558370-25-000943.md) | [2,389](/filings/0001558370-24-005892.md) | [2,284](/filings/0001558370-24-010241.md) | [2,197](/filings/0001558370-24-014135.md) | [2,137](/filings/0001104659-26-016358.md) | [2,073](/filings/0001558370-25-005551.md) | [2,006](/filings/0001558370-25-009609.md) | [1,865](/filings/0001104659-25-104919.md) | [1,845](/filings/0001104659-26-086641.md) | [1,796](/filings/0001104659-26-048542.md) | [1,643](/filings/0001104659-26-086641.md) |
| Current portion of debt | $m | [443](/filings/0001558370-23-016945.md) | [444](/filings/0001558370-25-000943.md) | [507](/filings/0001558370-24-005892.md) | [498](/filings/0001558370-24-010241.md) | [497](/filings/0001558370-24-014135.md) | [536](/filings/0001104659-26-016358.md) | [486](/filings/0001558370-25-005551.md) | [491](/filings/0001558370-25-009609.md) | [520](/filings/0001104659-25-104919.md) | [547](/filings/0001104659-26-086641.md) | [598](/filings/0001104659-26-048542.md) | [654](/filings/0001104659-26-086641.md) |
| Shareholders' equity | $m | [2,137](/filings/0001558370-24-014135.md) | [2,114](/filings/0001104659-26-016358.md) | [2,165](/filings/0001104659-25-104919.md) | [2,231](/filings/0001104659-25-104919.md) | [2,311](/filings/0001104659-25-104919.md) | [2,409](/filings/0001104659-26-086641.md) | [2,474](/filings/0001104659-26-086641.md) | [2,582](/filings/0001104659-26-086641.md) | [2,678](/filings/0001104659-25-104919.md) | [2,746](/filings/0001104659-26-086641.md) | [2,732](/filings/0001104659-26-086641.md) | [2,761](/filings/0001104659-26-086641.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [179 d](/filings/0001558370-24-014135.md) | [224 d](/filings/0001104659-26-016358.md) | [158](/filings/0001558370-25-005551.md) | [165 d](/filings/0001558370-25-009609.md) | [184 d](/filings/0001104659-25-104919.md) | [186 d](/filings/0001104659-26-016358.md) | [171](/filings/0001104659-26-048542.md) | [257 d](/filings/0001104659-26-086641.md) | [281 d](/filings/0001104659-25-104919.md) | [232 d](/filings/0001104659-26-016358.md) | [144](/filings/0001104659-26-048542.md) | [292 d](/filings/0001104659-26-086641.md) |
| Capital expenditure | $m | [48.3](/filings/0001558370-24-014135.md) | [(0.7) d](/filings/0001104659-26-016358.md) | [4.3](/filings/0001558370-25-005551.md) | [40.9](/filings/0001558370-25-009609.md) | [84.3](/filings/0001104659-25-104919.md) | [23.2 d](/filings/0001104659-26-016358.md) | [8.5](/filings/0001104659-26-048542.md) | [139](/filings/0001558370-25-009609.md) | [55.4](/filings/0001104659-25-104919.md) | [7.2 d](/filings/0001104659-26-016358.md) | [14.0](/filings/0001104659-26-048542.md) | [8.0 d](/filings/0001104659-26-086641.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [50.5 d](/filings/0001558370-23-016945.md) | not reported | [8.8](/filings/0001558370-24-005892.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.6](/filings/0001558370-23-016945.md) | [49.4](/filings/0001558370-24-005892.md) | [44.2](/filings/0001558370-24-010241.md) | [42.6](/filings/0001558370-24-014135.md) | [41.5](/filings/0001558370-25-005551.md) | [41.4](/filings/0001558370-25-009609.md) | [41.6](/filings/0001104659-25-104919.md) | [41.6](/filings/0001104659-26-048542.md) | [41.4](/filings/0001104659-26-086641.md) | [41.4](/filings/0001104659-25-104919.md) | [40.7](/filings/0001104659-26-048542.md) | [39.6](/filings/0001104659-26-086641.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 38,828,325 at 2026-07-17, from the cover of the [10-Q filed 2026-07-24](/filings/0001104659-26-086641.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.